Gelteq (GELS) Shares Outstanding (Weighted Average) (2023 - 2025)
Gelteq (GELS) recorded quarterly Shares Outstanding (Weighted Average) of $21.7 million in Q2 2025, down 1.04% quarter-over-quarter from $22.0 million in Q4 2024, and up 23.98% on a YoY basis from $17.5 million in Q2 2024.
Gelteq (GELS) Shares Outstanding (Weighted Average) (2023 - 2025) Analysis & Trends
Gelteq's Shares Outstanding (Weighted Average) history runs 3 years deep, the most recent figure standing at $21.7 million for Q2 2025.
- In Q2 2025, Shares Outstanding (Weighted Average) rose 23.98% year-over-year to $21.7 million; the TTM figure through Jun 2025 stood at $21.7 million (up 23.98% YoY), while the FY2025 annual figure was $21.7 million, up 23.98% from the prior year.
- Shares Outstanding (Weighted Average) was $21.7 million for Q2 2025 at Gelteq, down from $22.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $22.0 million in Q4 2024 to a low of $17.5 million in Q2 2024.
- Historically, Shares Outstanding (Weighted Average) has averaged $19.8 million across 3 years, with a median of $19.8 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) declined 1.4% in 2024, then climbed 23.98% in 2025.
- A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $17.8 million in 2023, then increased by 23.53% to $22.0 million in 2024, then dropped by 1.04% to $21.7 million in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $21.7 million (Q2 2025), $22.0 million (Q4 2024), and $17.5 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 64.74 Mn |
| 10 | Gelteq | 10.57 Mn | 10.34 Mn | - | 21.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 21.74 Mn |
| Dec 31, 2024 | 21.97 Mn |
| Jun 30, 2024 | 17.54 Mn |
| Jun 30, 2023 | 17.78 Mn |